Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis

Michelle L Tas, Lisa W Dootjes, Marta Fiocco, Ronald R de Krijger, Miranda P Dierselhuis, Natasha K A van Eijkelenburg, Martine van Grotel, Kathelijne C J M Kraal, Annemarie M L Peek, Godelieve A M Tytgat, Max M van Noesel

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis'. Together they form a unique fingerprint.

Medicine & Life Sciences